(AOF) – Carmat, designer and developer of the most advanced total artificial heart in the world, announces the completion of its capital increase with elimination of shareholders’ preferential subscription rights by way of public offering, for a total gross amount ( including the share premium) of €16.5 million including the partial exercise of the over-allotment option granted by the Company to the Lead Manager and Bookrunner for a gross amount of €1.5 million.
Following this capital increase, Carmat estimates its financing needs over the next 12 months at 50 or 35 million euros, depending on the results of its ongoing discussions with its financial creditors (in particular the European Investment Bank ), which are expected during the first quarter of 2024.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
